Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / E14 Spv Culture Biosciences B LLC

E14 Spv Culture Biosciences B LLC

MatureClosed to new capitalSPV or co-invest vehicleADV: Venture Capital FundE14 Management, LLCDelaware
Amounts, each with its basis
Vintage
2021basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$4.7Mwhat may be sold, not what was raised; file 021-415698, sworn by the adviser or filed under this vehicle
Form D sold
$4.7Mas of the filing of Oct 5, 2021, 8 investors
First sale
Sep 20, 2021
Reported GAV
$4.6Mon the Form ADV filed Mar 28, 2024; the fund's assets, never its size or dry powder
Owners (ADV)
8
Reported on ADV
Mar 30, 2022 to Mar 28, 2024
Fundraising evidence
Closed to new capital
Form D filed or amended 2021-10-05: the stated $4.7M offering reported fully sold (fr-1)
evidence dated Oct 5, 2021. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Mature
vintage 4 to 7 years
age years: 5first sale: 2021-09-20vintage year: $2,021adv gav as of: 2024-03-28vintage basis: form_d_first_saleform d sold usd: $4.7Mform d offering usd: $4.7Mform d latest filed at: 2021-10-05
The fund's own reporting through time
4 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 30, 2022Venture Capital Fund$4.7M
80%yes
Mar 31, 2023Venture Capital Fund$4.7M
80%yes
May 3, 2023Venture Capital Fund$4.7M
80%yes
Mar 28, 2024Venture Capital Fund$4.6M
80%no
Principals and agents
3 principals on Form D, 0 placement agents
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
  1. Mar 30, 2022
    E14 Spv Culture Biosciences B LLC first reported on Form ADV by E14 Management, LLC (Venture Capital Fund), GAV $4,661,195
    Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Oct 5, 2021
    E14 SPV Culture Biosciences B LLC filed Form D: $4,680,085 sold of $4,680,085, Venture Capital Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this vehicle